Structural and functional insights into Spns2-mediated transport of sphingosine-1-phosphate
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Summary: Sphingosine-1-phosphate (S1P) is an important signaling sphingolipid that regulates the immune system, angiogenesis, auditory function, and epithelial and endothelial barrier integrity. Spinster homolog 2 (Spns2) is an S1P transporter that exports S1P to initiate lipid signaling cascades. Modulating Spns2 activity can be beneficial in treatments of cancer, inflammation, and immune diseases. However, the transport mechanism of Spns2 and its inhibition remain unclear. Here we present six cryo-EM structures of human Spns2 in lipid nanodiscs, including two functionally relevant intermediate conformations that link the inward- and outward-facing states, to reveal the structural basis of the S1P transport cycle. Functional analyses suggest that Spns2 exports S1P via facilitated diffusion, a mechanism distinct from other MFS lipid transporters. Finally, we show that the Spns2 inhibitor 16d attenuates the transport activity by locking Spns2 in the inward-facing state. Our work sheds light on Spns2-mediated S1P transport and aids the development of advanced Spns2 inhibitors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Highly accurate protein structure prediction with AlphaFold
Jumper, J., Evans, R., Pritzel, A., Green, T., Figurnov, M., Ronneberger, O., Tunyasuvunakool, K., Bates, R., Žídek, A., Potapenko, A., et al. (2021) · Nature · doi:10.1038/s41586-021-03819-2 · Cited by 43,764
CHARMM‐GUI: A web‐based graphical user interface for CHARMM
Jo, S., Kim, T., Iyer, V. G., & Im, W. (2008) · Journal of Computational Chemistry · doi:10.1002/jcc.20945 · Cited by 9,284
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis
Brinkmann, V., Billich, A., Baumruker, T., Heining, P., Schmouder, R., Francis, G., Aradhye, S., & Burtin, P. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3248 · Cited by 1,273
Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid
Nguyen, L. N., Ma, D., Shui, G., Wong, P., Cazenave-Gassiot, A., Zhang, X., Wenk, M. R., Goh, E. L. K., & Silver, D. L. (2014) · Nature · doi:10.1038/nature13241 · Cited by 1,048
Crystal structure of the human glucose transporter GLUT1
Deng, D., Xu, C., Sun, P., Wu, J., Yan, C., Hu, M., & Yan, N. (2014) · Nature · doi:10.1038/nature13306 · Cited by 777
High-affinity binders selected from designed ankyrin repeat protein libraries
Binz, H. K., Amstutz, P., Kohl, A., Stumpp, M. T., Briand, C., Forrer, P., Grütter, M. G., & Plückthun, A. (2004) · Nature Biotechnology · doi:10.1038/nbt962 · Cited by 656
Research works printed but not linked: 60
- Cartier, 2019, Sphingosine 1-phosphate: lipid signaling in pathology and therapy, Science, 366, 10.1126/science.aar5551 · DOI · Paper page
- Rosen, 2013, Sphingosine-1-phosphate and its receptors: structure, signaling, and influence, Annu. Rev. Biochem., 82, 637, 10.1146/annurev-biochem-062411-130916 · DOI · Paper page
- Proia, 2015, Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy, J. Clin. Invest., 125, 1379, 10.1172/JCI76369 · DOI · Paper page
- Green, 2021, Sphingolipids in metabolic disease: the good, the bad, and the unknown, Cell Metab., 33, 1293, 10.1016/j.cmet.2021.06.006 · DOI · Paper page
- Lu, 2019, G-protein coupled receptors and ligands that organize humoral immune responses, Immunol. Rev., 289, 158, 10.1111/imr.12743 · DOI
- Spiegel, 2019, New insights into functions of the sphingosine-1-phosphate transporter SPNS2, J. Lipid Res., 60, 484, 10.1194/jlr.S091959 · DOI
- Kawahara, 2009, The sphingolipid transporter spns2 functions in migration of zebrafish myocardial precursors, Science, 323, 524, 10.1126/science.1167449 · DOI · Paper page
- Osborne, 2008, The spinster homolog, two of hearts, is required for sphingosine 1-phosphate signaling in zebrafish, Curr. Biol., 18, 1882, 10.1016/j.cub.2008.10.061 · DOI · Paper page
- Nagahashi, 2013, Spns2, a transporter of phosphorylated sphingoid bases, regulates their blood and lymph levels, and the lymphatic network, FASEB J., 27, 1001, 10.1096/fj.12-219618 · DOI · Paper page
- Vu, 2017, Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets, Nature, 550, 524, 10.1038/nature24053 · DOI · Paper page
- Kobayashi, 2018, MFSD2B is a sphingosine 1-phosphate transporter in erythroid cells, Sci. Rep., 8, 10.1038/s41598-018-23300-x · DOI
- Hisano, 2012, Mouse SPNS2 functions as a sphingosine-1-phosphate transporter in vascular endothelial cells, PLoS One, 7, 10.1371/journal.pone.0038941 · DOI · Paper page
- Fukuhara, 2012, The sphingosine-1-phosphate transporter Spns2 expressed on endothelial cells regulates lymphocyte trafficking in mice, J. Clin. Invest., 122, 1416, 10.1172/JCI60746 · DOI · Paper page
- Nijnik, 2012, The role of sphingosine-1-phosphate transporter Spns2 in immune system function, J. Immunol., 189, 102, 10.4049/jimmunol.1200282 · DOI · Paper page
- Hisano, 2011, The sphingosine 1-phosphate transporter, SPNS2, functions as a transporter of the phosphorylated form of the immunomodulating agent FTY720, J. Biol. Chem., 286, 1758, 10.1074/jbc.M110.171116 · DOI · Paper page
- Kappos, 2010, A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis, N. Engl. J. Med., 362, 387, 10.1056/NEJMoa0909494 · DOI · Paper page
- Chen, 2014, Spinster homolog 2 (spns2) deficiency causes early onset progressive hearing loss, PLoS Genet., 10, 10.1371/journal.pgen.1004688 · DOI · Paper page
- Fang, 2018, S1P transporter SPNS2 regulates proper postnatal retinal morphogenesis, FASEB J., 32, 3597, 10.1096/fj.201701116R · DOI
- Donoviel, 2015, Spinster 2, a sphingosine-1-phosphate transporter, plays a critical role in inflammatory and autoimmune diseases, FASEB J., 29, 5018, 10.1096/fj.15-274936 · DOI · Paper page
- Okuniewska, 2021, SPNS2 enables T cell egress from lymph nodes during an immune response, Cell Rep., 36, 10.1016/j.celrep.2021.109368 · DOI
- van der Weyden, 2017, Genome-wide in vivo screen identifies novel host regulators of metastatic colonization, Nature, 541, 233, 10.1038/nature20792 · DOI · Paper page
- Yasuda, 2022, Anomaly of cornea and ocular adnexa in spinster homolog 2 (Spns2) knockout mice, Ocul. Surf., 26, 111, 10.1016/j.jtos.2022.08.007 · DOI
- Quistgaard, 2016, Understanding transport by the major facilitator superfamily (MFS): structures pave the way, Nat. Rev. Mol. Cell Biol., 17, 123, 10.1038/nrm.2015.25 · DOI · Paper page
- He, 2022, Spns1 is a lysophospholipid transporter mediating lysosomal phospholipid salvage, Proc. Natl. Acad. Sci. US A, 119, 10.1073/pnas.2210353119 · DOI
- Cater, 2021, Structural basis of omega-3 fatty acid transport across the blood-brain barrier, Nature, 595, 315, 10.1038/s41586-021-03650-9 · DOI · Paper page
- Wood, 2021, Structure and mechanism of blood-brain-barrier lipid transporter MFSD2A, Nature, 596, 444, 10.1038/s41586-021-03782-y · DOI · Paper page
- Martinez-Molledo, 2022, Structural insights into the lysophospholipid brain uptake mechanism and its inhibition by syncytin-2, Nat. Struct. Mol. Biol., 29, 604, 10.1038/s41594-022-00786-8 · DOI
- Dastvan, 2022, Proton-driven alternating access in a spinster lipid transporter, Nat. Commun., 13, 10.1038/s41467-022-32759-2 · doi:10.1038/s41467-022-32759-2
- Goto, 2021, Direct uptake of sphingosine-1-phosphate independent of phospholipid phosphatases, J. Biol. Chem., 296, 10.1016/j.jbc.2021.100605 · DOI
- Fritzemeier, 2022, Discovery of in vivo active sphingosine-1-phosphate transporter (Spns2) inhibitors, J. Med. Chem., 65, 7656, 10.1021/acs.jmedchem.1c02171 · DOI
- Kobayashi, 2016, Fluorescence-based rapid measurement of sphingosine-1-phosphate transport activity in erythrocytes, J. Lipid Res., 57, 2088, 10.1194/jlr.D071068 · DOI
- Flayhan, 2018, Saposin lipid nanoparticles: A highly versatile and modular tool for membrane protein research, Structure, 26, 345, 10.1016/j.str.2018.01.007 · DOI
- Quek, 2016, Structural insights into the transport mechanism of the human sodium-dependent lysophosphatidylcholine transporter MFSD2A, J. Biol. Chem., 291, 9383, 10.1074/jbc.M116.721035 · DOI · Paper page
- Tanaka, 2022, Sphingosine 1-phosphate signaling in perivascular cells enhances inflammation and fibrosis in the kidney, Sci. Transl. Med., 14, 10.1126/scitranslmed.abj2681 · DOI
- Christoffersen, 2011, Endothelium-protective sphingosine-1-phosphate provided by HDL-associated apolipoprotein M, Proc. Natl. Acad. Sci. US A, 108, 9613, 10.1073/pnas.1103187108 · DOI · Paper page
- Swendeman, 2017, An engineered S1P chaperone attenuates hypertension and ischemic injury, Sci. Signal., 10, 10.1126/scisignal.aal2722 · DOI
- Nomura, 2015, Structure and mechanism of the mammalian fructose transporter GLUT5, Nature, 526, 397, 10.1038/nature14909 · DOI · Paper page
- Drew, 2021, Structures and general transport mechanisms by the major facilitator superfamily (MFS), Chem. Rev., 121, 5289, 10.1021/acs.chemrev.0c00983 · DOI · Paper page
- Zheng, 2017, MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy, Nat. Methods, 14, 331, 10.1038/nmeth.4193 · DOI · Paper page
- Rohou, 2015, CTFFIND4: fast and accurate defocus estimation from electron micrographs, J. Struct. Biol., 192, 216, 10.1016/j.jsb.2015.08.008 · DOI · Paper page
- Zivanov, 2018, New tools for automated high-resolution cryo-EM structure determination in RELION-3, eLife, 7, 10.7554/eLife.42166 · DOI · Paper page
- Wagner, 2019, SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM, Commun. Biol., 2, 10.1038/s42003-019-0437-z · DOI · Paper page
- Bepler, 2019, Positive-unlabeled convolutional neural networks for particle picking in cryo-electron micrographs, Nat. Methods, 16, 1153, 10.1038/s41592-019-0575-8 · DOI · Paper page
- Punjani, 2017, cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination, Nat. Methods, 14, 290, 10.1038/nmeth.4169 · DOI · Paper page
- Pettersen, 2004, UCSF Chimera--a visualization system for exploratory research and analysis, J. Comp. Chem., 25, 1605, 10.1002/jcc.20084 · DOI · Paper page
- Emsley, 2004, Coot: model-building tools for molecular graphics, Acta Crystallogr. D Biol. Crystallogr., 60, 2126, 10.1107/S0907444904019158 · DOI · Paper page
- Adams, 2010, Phenix: a comprehensive Python-based system for macromolecular structure solution, Acta Crystallogr. D Biol. Crystallogr., 66, 213, 10.1107/S0907444909052925 · DOI · Paper page
- Chen, 2010, MolProbity: all-atom structure validation for macromolecular crystallography, Acta Crystallogr. D Biol. Crystallogr., 66, 12, 10.1107/S0907444909042073 · DOI · Paper page
- Brooks, 1983, CHARMM: A program for macromolecular energy, minimization, and dynamics calculations, J. Comp. Chem., 4, 187, 10.1002/jcc.540040211 · DOI · Paper page
- Li, 2005, Very fast empirical prediction and rationalization of protein pKa values, Proteins, 61, 704, 10.1002/prot.20660 · DOI · Paper page
- Phillips, 2005, Scalable molecular dynamics with NAMD, J. Comp. Chem., 26, 1781, 10.1002/jcc.20289 · DOI · Paper page
- Sullards, 2011, Analysis of mammalian sphingolipids by liquid chromatography tandem mass spectrometry (LC-MS/MS) and tissue imaging mass spectrometry (TIMS), Biochim. Biophys. Acta, 1811, 838, 10.1016/j.bbalip.2011.06.027 · DOI · Paper page
- Mendoza, 2012, The transporter Spns2 is required for secretion of lymph but not plasma sphingosine-1-phosphate, Cell Rep., 2, 1104, 10.1016/j.celrep.2012.09.021 · DOI · Paper page
- Goehring, 2014, Screening and large-scale expression of membrane proteins in mammalian cells for structural studies, Nat. Protoc., 9, 2574, 10.1038/nprot.2014.173 · DOI · Paper page
- Rana, 2018, An improved strategy for fluorescent tagging of membrane proteins for overexpression and purification in mammalian cells, Biochemistry, 57, 6741, 10.1021/acs.biochem.8b01070 · DOI
- Vanommeslaeghe, 2010, CHARMM general force field: a force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields, J. Comp. Chem., 31, 671, 10.1002/jcc.21367 · DOI · Paper page
- Lomize, 2006, OPM: orientations of proteins in membranes database, Bioinformatics, 22, 623, 10.1093/bioinformatics/btk023 · DOI · Paper page
- Jorgensen, 1983, Comparison of simple potential functions for simulating liquid water, J. Chem. Phys., 79, 9
- MacKerell, 1998, All-atom empirical potential for molecular modeling and dynamics studies of proteins, J. Phys. Chem. B, 102, 3586, 10.1021/jp973084f · DOI · Paper page
- Essmann, 1995, A smooth particle mesh Ewald method, J. Chem. Phys., 103, 8577, 10.1063/1.470117 · DOI · Paper page
Cited by
Transport and inhibition of the sphingosine-1-phosphate exporter SPNS2
(2025) · doi:10.1038/s41467-025-55942-7 · Cited by 15
Structural mechanisms for VMAT2 inhibition by tetrabenazine
Dalton, M. P., Cheng, M. H., Bahar, I., & Coleman, J. A. (2024) · eLife · doi:10.7554/elife.91973.4 · Cited by 14
Structural mechanisms for VMAT2 inhibition by tetrabenazine
Dalton, M. P., Cheng, M. H., Bahar, I., & Coleman, J. A. (2023) · doi:10.1101/2023.09.05.556211 · Cited by 6
Molecular basis of prostaglandin E2 reuptake by organic anion transporter PGT
Zhu, Z., Li, Y., Xia, H., Yang, C., Zhou, Z., Chao, Y., Ba, Q., Li, D., & Qu, Q. (2025) · Nature Communications · doi:10.1038/s41467-025-67025-8 · Cited by 2
Structural mechanisms for VMAT2 inhibition by tetrabenazine
Dalton, M. P., Cheng, M. H., Bahar, I., & Coleman, J. A. (2024) · doi:10.7554/elife.91973.3
Metadata
- Authors
- Chen, H., Ahmed, S., Zhao, H., Elghobashi-Meinhardt, N., Dai, Y., Kim, J. H., McDonald, J. G., Li, X., & Lee, C.-H.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2023-06
- Volume
- 186
- Issue
- 12
- Pages
- 2644-2655.e16
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W4377694932
- Cited by
- 63
- References
- 6
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 373 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Funders
- St. Jude Children's Research Hospital
- American Lebanese Syrian Associated Charities
- National Institutes of Health (1P30DK127984, P01 HL160487, R01 GM135343)
- Welch Foundation (I-1957, R01 GM143282)
- Cancer Prevention and Research Institute of Texas (RP170644)
- Damon Runyon Cancer Research Foundation (DRR-53S-19)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.